Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doppler evaluation and 12-month follow-up in rheumatoid arthritis patients treated with adalimumab
2012-002573-62Phase 4Terminated
- Sponsor
- Karolinska Institutet
- Start
- Aug 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Karolinska Institutet. Started Aug 2012; status: terminated.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-002573-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002573-62.